| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/01/1997 | CA2043003C Infant formula |
| 07/01/1997 | CA2027133C Inclusion complexes with silybinin, their preparation and pharmaceutical compositions containing them |
| 07/01/1997 | CA2012381C Reduced calorie fat compositions containing polyol polyesters and reduced calorie triglycerides |
| 06/26/1997 | WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | WO1997022604A1 Novel substituted 4-(1h-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases |
| 06/26/1997 | WO1997022603A1 Method for the synthesis of a benzimidazole compound |
| 06/26/1997 | WO1997022597A1 Piperazine derivatives as tachykinin antagonists |
| 06/26/1997 | WO1997018816A3 Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders and other applications |
| 06/26/1997 | CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme |
| 06/25/1997 | EP0780388A1 5HT1Dalpha and 5HT2A ligands |
| 06/25/1997 | EP0780386A1 Matrix metalloprotease inhibitors |
| 06/25/1997 | EP0780128A2 Crotonic acid amide derivatives and lipoprotein containing compositions |
| 06/25/1997 | EP0779819A1 Therapeutic treatment of clostridium difficile associated diseases |
| 06/25/1997 | EP0779816A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response |
| 06/25/1997 | EP0706376B1 Anti-angiogenic compositions and methods of use |
| 06/25/1997 | EP0696199A4 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
| 06/25/1997 | EP0538486B1 Sewing machine needle and method of manufacturing same |
| 06/25/1997 | CN1152940A Non-splicing variants of gp 350/220 |
| 06/25/1997 | CN1152919A Triazole compounds and their use as dopamine-D3-ligands |
| 06/25/1997 | CN1152871A Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor |
| 06/25/1997 | CN1152456A Series products for preventing and curing liver disease and production technology thereof |
| 06/24/1997 | US5641875 Dna construct encoding immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cell comprising same |
| 06/24/1997 | US5641863 Immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cells comprising same |
| 06/24/1997 | US5641800 Alleviate effect of septic shock, adult respiratory distress syndrome, pancreatitis, trauma, bronchial asthma, allergic rhinitis, and rheumatoid arthritis |
| 06/24/1997 | US5641797 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd] indoles |
| 06/24/1997 | US5641792 Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation and pharmaceutical compositions containing them |
| 06/24/1997 | US5641786 Quinuclidine derivatives |
| 06/24/1997 | US5641777 Neurokinin receptor antagonist |
| 06/24/1997 | US5641775 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or antagonists |
| 06/24/1997 | US5641669 Platelet-activating factor acetylhydrolase |
| 06/24/1997 | US5641662 Transfection of lung via aerosolized transgene delivery |
| 06/24/1997 | US5641475 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 06/19/1997 | WO1997021731A1 Assay for and uses of peptide hormone receptor ligands |
| 06/19/1997 | WO1997021716A1 NAPHTHYL GLYOXAMIDES AS sPLA2 INHIBITORS |
| 06/19/1997 | WO1997021707A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021704A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021703A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021702A1 3-benzylaminopyrrolidines and -piperidines as tachykinin receptor antagonists |
| 06/19/1997 | WO1997021690A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 06/19/1997 | WO1997021670A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 06/19/1997 | WO1997021665A1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors |
| 06/19/1997 | WO1997021664A1 NAPHTHYL ACETAMIDES AS sPLA2 INHIBITORS |
| 06/19/1997 | WO1997021439A1 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness |
| 06/19/1997 | WO1997021435A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021416A2 Glycoconjugates of opiated substances |
| 06/19/1997 | DE19546452A1 Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel New Phenylamidinderivate, processes for their Herstelung and their use as medicaments |
| 06/19/1997 | CA2240395A1 Naphthyl acetamides as spla2 inhibitors |
| 06/19/1997 | CA2240115A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240111A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240108A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240048A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2239293A1 Assay for and uses of peptide hormone receptor ligands |
| 06/19/1997 | CA2238711A1 3-benzylaminopyrrolidines and piperidines as tachykinin receptor antagonists |
| 06/19/1997 | CA2238175A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 06/19/1997 | CA2211596A1 Glycoconjugates of opiated substances |
| 06/19/1997 | CA2211161A1 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness |
| 06/18/1997 | EP0779273A1 Naphthyl glyoxamides as sPLA2 inhibitors |
| 06/18/1997 | EP0779271A1 Naphthyl acetamides as sPLA2 inhibitors |
| 06/18/1997 | EP0778948A1 Predictive test for hepatitis-b resistance |
| 06/18/1997 | EP0778834A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 06/18/1997 | EP0778831A1 Morpholine derivatives and their use as therapeutic agents |
| 06/18/1997 | EP0494264B1 Inhibiting transforming growth factor to prevent accumulation of extracellular matrix |
| 06/18/1997 | CN1152337A Superoxide dismutase-4 |
| 06/18/1997 | CN1152313A Process for preparation of 2-(1-azabicyclo(2,2,2)oct-3-yl)-2,4,5,6-tetrahydro-1H-benz (DE)isoquinolin-1-1one and intermediate product |
| 06/18/1997 | CN1152311A Anti-helicobacter acyl derivatives of azolones |
| 06/18/1997 | CN1152310A Anti-helicobacter heterocyclic derivatives of azolines |
| 06/18/1997 | CN1152309A Anti-helicobacter urea and thiourea derivatives of azolones |
| 06/18/1997 | CN1152308A Sulfonamide derivatives of azolones anti-helicobacter agents |
| 06/18/1997 | CN1152304A Substituted benzamidines, their production and their use as medicaments |
| 06/18/1997 | CN1152303A Novel chemical compound, its preparation and use as drug |
| 06/18/1997 | CN1152259A Use of thioketene derivatives for preventing or treating hepatitis B |
| 06/18/1997 | CN1151986A N-methyl-n-£(1s)-1-phenyl-2-((3s)-3-hydroxypyrrolidin-1-yl) ethyl-2,2-diphenylacetamide |
| 06/18/1997 | CN1151893A Combination antiemetic therapy using NK-1 receptor antagonists |
| 06/17/1997 | US5639783 Ketone derivatives |
| 06/17/1997 | US5639754 Bactericides treating helicobacter infection |
| 06/17/1997 | US5639746 Inhibitors of metalloprotease |
| 06/17/1997 | US5639634 Useful for diagnosing tumors and targeting drug delivery |
| 06/12/1997 | WO1997020572A1 Pharmaceutical compositions for oral use including an nsaid and ceramides |
| 06/12/1997 | WO1997020563A1 Ligands to enhance cellular uptake of biomolecules |
| 06/12/1997 | WO1997020562A1 Cisapride sustained release |
| 06/12/1997 | WO1997020559A1 Use of fungicidal agents for selective decontamination of teeth and dental prostheses |
| 06/12/1997 | CA2239409A1 Use of fungicidal agents for selective decontamination of teeth and dental prostheses |
| 06/12/1997 | CA2238379A1 Ligands to enhance cellular uptake of biomolecules |
| 06/12/1997 | CA2232489A1 Cisapride sustained release |
| 06/11/1997 | EP0778277A1 Substituted heterocyclic derivatives as CRF antagonists |
| 06/11/1997 | EP0778025A1 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals |
| 06/11/1997 | EP0777729A1 5-lipoxygenase-activating protein ii |
| 06/11/1997 | EP0777687A1 Trefoil peptide dimer |
| 06/11/1997 | EP0777684A1 Calcitonin receptor |
| 06/11/1997 | EP0777661A1 Natriuretic and anti-hypertensive compounds |
| 06/11/1997 | EP0777659A1 Morpholine derivatives and their use as therapeutic agents |
| 06/11/1997 | EP0777646A1 Metalloproteinase inhibitors |
| 06/11/1997 | EP0777493A1 Calcitonin gene related peptide receptor |
| 06/11/1997 | EP0777482A1 Combined preparation for the therapy of immune diseases |
| 06/11/1997 | EP0777481A1 Use of n-substituted phenothiazines |
| 06/11/1997 | EP0777471A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 06/11/1997 | EP0777470A1 Use of paracellular absorption enhancers such as glucose for enhancing the absorption of histamine h2-antagonists |
| 06/11/1997 | EP0656786A4 Health supplements containing phyto-oestrogens, analogues or metabolites thereof. |
| 06/11/1997 | CN1151758A Novel growth of differentiation factor of the TGF- 'beta' family |
| 06/11/1997 | CN1151699A Health compsn. |